Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
P3BEP
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- NCT02582697 ↗
- Recruiting
- University of Sydney
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Germ Cell Tumor
- Interventions
- Bleomycin (active name: Bleomycin Sulfate); Etoposide; Cisplatin; Pegylated G-CSF (Pegfilgrastim); Filgrastim
- Arms
- Standard Arm - Standard BEP · Active comparator
- Experimental Arm - Accelerated BEP · Experimental
- Enrollment
- 500 (estimated)
- Primary outcomes
- Progression-free survival (disease progression or death)
- Sponsor
- University of Sydney with Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Cambridge University Hospitals NHS Foundation Trust, Cancer Trials Ireland, Children's Oncology Group, Dana-Farber Cancer Institute, University of Southern California
- Start
- Feb 2014
- Primary completion
- Dec 31, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT02582697 · updated Sep 1, 2026
Publications
linked from the registry- Lawrence NJ, Chan H, Toner G, Stockler MR, Martin A, Yip S, Wong N, Yeung A, Mazhar D, Pashankar F, Frazier L, McDermott R, Walker R, Tan H, Davis ID, Grimison P; ANZUP. Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer. 2018 Aug 29;18(1):854. doi: 10.1186/s12885-018-4745-3. PubMed 30157803